BCCIP
Basic information
Region (hg38): 10:125823546-125853695
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCCIP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 119 | 68 | 193 | |||
Total | 0 | 0 | 130 | 70 | 6 |
Variants in BCCIP
This is a list of pathogenic ClinVar variants found in the BCCIP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-125823567-A-G | not specified | Uncertain significance (Sep 27, 2021) | ||
10-125823570-T-C | not specified | Likely benign (May 11, 2022) | ||
10-125823576-C-G | not specified | Uncertain significance (Jul 10, 2024) | ||
10-125823589-A-G | not specified | Likely benign (Sep 28, 2022) | ||
10-125823632-C-G | not specified | Uncertain significance (Jan 10, 2023) | ||
10-125823645-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
10-125823675-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
10-125826598-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
10-125827609-C-G | not specified | Uncertain significance (Jul 10, 2024) | ||
10-125827614-G-C | not specified | Uncertain significance (Jul 05, 2024) | ||
10-125827619-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
10-125830569-A-G | not specified | Uncertain significance (Mar 19, 2024) | ||
10-125831459-C-T | not specified | Uncertain significance (Aug 29, 2024) | ||
10-125831460-G-A | not specified | Uncertain significance (Jul 28, 2021) | ||
10-125833783-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
10-125833792-A-C | not specified | Uncertain significance (Jan 03, 2022) | ||
10-125833892-C-G | not specified | Uncertain significance (Aug 21, 2023) | ||
10-125833905-G-A | not specified | Uncertain significance (Feb 13, 2023) | ||
10-125833906-C-T | not specified | Uncertain significance (Nov 15, 2024) | ||
10-125836697-G-T | not specified | Uncertain significance (Jan 23, 2024) | ||
10-125836701-A-T | Uncertain significance (Feb 21, 2023) | |||
10-125836702-T-C | Likely benign (Jul 25, 2022) | |||
10-125836702-TC-GA | Uncertain significance (Jan 09, 2024) | |||
10-125836710-C-G | not specified | Uncertain significance (Jan 15, 2024) | ||
10-125836723-C-T | Likely benign (Sep 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BCCIP | protein_coding | protein_coding | ENST00000368759 | 8 | 30150 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00785 | 0.979 | 125676 | 0 | 72 | 125748 | 0.000286 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0989 | 175 | 171 | 1.02 | 0.00000823 | 2133 |
Missense in Polyphen | 19 | 31.426 | 0.60459 | 430 | ||
Synonymous | 0.416 | 62 | 66.3 | 0.935 | 0.00000342 | 589 |
Loss of Function | 2.17 | 6 | 15.1 | 0.397 | 6.38e-7 | 198 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000370 | 0.000304 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000469 | 0.0000462 |
European (Non-Finnish) | 0.000533 | 0.000519 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000704 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: During interphase, required for microtubule organizing and anchoring activities. During mitosis, required for the organization and stabilization of the spindle pole (PubMed:28394342). Isoform 2/alpha is particularly important for the regulation of microtubule anchoring, microtubule stability, spindle architecture and spindle orientation, compared to isoform 1/beta (PubMed:28394342). May promote cell cycle arrest by enhancing the inhibition of CDK2 activity by CDKN1A. May be required for repair of DNA damage by homologous recombination in conjunction with BRCA2. May not be involved in non-homologous end joining (NHEJ). {ECO:0000269|PubMed:10878006, ECO:0000269|PubMed:14726710, ECO:0000269|PubMed:15539944, ECO:0000269|PubMed:15713648, ECO:0000269|PubMed:17947333, ECO:0000269|PubMed:28394342}.;
Recessive Scores
- pRec
- 0.0887
Intolerance Scores
- loftool
- 0.917
- rvis_EVS
- -0.71
- rvis_percentile_EVS
- 14.4
Haploinsufficiency Scores
- pHI
- 0.311
- hipred
- Y
- hipred_score
- 0.624
- ghis
- 0.635
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0207
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bccip
- Phenotype
Gene ontology
- Biological process
- ribosomal large subunit export from nucleus;regulation of cyclin-dependent protein serine/threonine kinase activity;establishment of mitotic spindle orientation;microtubule cytoskeleton organization;DNA repair;cellular response to DNA damage stimulus;mitotic spindle organization;microtubule anchoring;neuroendocrine cell differentiation;mitotic spindle assembly
- Cellular component
- nucleus;nucleoplasm;centrosome;centriole;cytosol;nuclear cyclin-dependent protein kinase holoenzyme complex;mitotic spindle pole
- Molecular function
- RNA binding;protein binding;tubulin binding;kinase regulator activity